India, March 26 -- Pune-based startup In-Med Prognostics has announced the launch of Oncoshield CT tool for clinical decision support in diagnosing and treating liver and pancreatic cancers.

In-Med Oncoshield software automatically detects and quantifies lesions in liver and pancreas in CT scans. It automatically calculates volumes and identifies locations of lesions. This significantly enhances diagnostic capabilities and improves patient care especially in preparing for surgery. These insights are produced with over 90% accuracy and very speedily in a matter of minutes.

In-Med's Oncoshield assists radiologists in the early detection of liver lesions. Early detection is crucial for prompt medical intervention and improved patient outco...